Key result
Social determinants of health and treatment exposures contribute to increased cardiotoxicity and cardiovascular disease risk among Black breast cancer survivors.
Why the study?
Black women experience higher rates of cardiotoxicity and CVD-related comorbidities than White women, driven by earlier CVD risk factor onset, SDOH, and disparities in screening and surveillance.
Highlights the importance of addressing social determinants of health to reduce cardio-oncology disparities in Black breast cancer survivors.
Supports integrating SDOH assessment into Black breast cancer survivorship care; leaves open causal mechanisms and targeted interventions.
BACKGROUND: Black women experience higher rates of cardiotoxicity and cardiovascular disease (CVD)-related comorbidities than White women. These racial and ethnic disparities are primarily from the earlier onset of CVD risk factors, social determinants of health (SDOH), and cardiotoxicity screening and surveillance disparities. OBJECTIVES: This article discusses the role of SDOH in cardio-oncology and strategies to prevent and detect adverse cardiovascular outcomes among Black breast cancer survivors. METHODS: Preliminary case study findings are presented, including treatment exposures to cardiotoxicity and SDOH in cardio-oncology influencing health outcomes in Black breast cancer survivors. FINDINGS: Nurses can address SDOH and racial disparities in cardio-oncology by being mindful of Black breast cancer survivors' increased burden of CVD risk factors, evaluating barriers to receive preventive care and cardio-oncology rehabilitation, practicing cultural humility, and adhering to evidence-based guidelines for behavioral risk management for Black breast cancer survivors.
No takes yet. Share an insight, caveat, or question.
Cousin et al. (2021) conducted a review in Breast cancer and cardiovascular disease risk. Social determinants of health was evaluated. Social determinants of health and treatment exposures contribute to increased cardiotoxicity and cardiovascular disease risk among Black breast cancer survivors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: